

	Maturity Date	As of March 31, 2013			As of December 31, 2012
New Revolving Credit Facility⁽¹⁾	April 2016	$	—		$	—
New Term Loan A Facility⁽¹⁾	April 2016	1,926,577			2,083,462
New Term Loan B Facility⁽¹⁾⁽²⁾	February 2019	1,265,726			1,275,167
New Incremental Term Loan B Facility⁽¹⁾⁽²⁾	December 2019	973,765			973,988
Senior Notes:
6.50%	July 2016	915,500			915,500
6.75%	October 2017	498,394			498,305
6.875%	December 2018	939,502			939,277
7.00%	October 2020	686,768			686,660
6.75%	August 2021	650,000			650,000
7.25%	July 2022	541,562			541,335
6.375%⁽³⁾	October 2020	1,725,325			1,724,520
6.375%⁽³⁾	October 2020	492,950			492,720
Convertible Notes:
1.375% Convertible Notes⁽⁴⁾	June 2017	209			228,576
2.50% Convertible Notes⁽⁴⁾	June 2032	—			5,133
1.50% Convertible Notes⁽⁴⁾	June 2033	—			84
Other		842			898
		10,617,120			11,015,625
Less current portion		(289,676		)	(480,182		)
Total long-term debt		$	10,327,444		$	10,535,443

____________________________________


(1)	Together, the “Senior Secured Credit Facilities” under the Company’s Third Amended and Restated Credit and Guaranty Agreement (the “Credit Agreement”).

(2)

On February 21, 2013, the Company and certain of its subsidiaries, as guarantors, entered into an amendment to the Credit Agreement to effectuate a repricing of its existing senior secured term loan B facility (the “Term Loan B Facility”) and its existing incremental term B loans (the “Incremental Term Loan B Facility”) by the issuance of $1.3 billion and $1.0 billion in new incremental term loans (the “New Term Loan B Facility” and the “New Incremental Term Loan B Facility”, respectively, and together, the “Repriced Term Loan B Facilities”).

(3)

On March 29, 2013, the Company announced that its wholly owned subsidiary Valeant commenced an offer to exchange (the “Exchange Offer”) any and all of its outstanding $500.0 million aggregate principal amount of 6.375% senior notes due 2020 (the “Existing Notes”) into the current outstanding $1.75 billion 6.375% senior notes due 2020. Valeant conducted the Exchange Offer in order to satisfy its obligations under the indenture governing the Existing Notes with the anticipated result being that some or all of such notes will be part of a single series of 6.375% senior notes under one indenture. The Exchange Offer, which did not result in any changes to existing terms or to the total amount of the Company’s debt outstanding, expired on April 26, 2013. $497.7 million of aggregate principal amount of the Existing Notes was exchanged as of such date.


(4)	Represents obligations assumed from Medicis.